Number of Shares
5.75 Mil
Current Holdings Value*
$7.82 Mil
% of Portfolio
6.33%
Total Estimate Gain
$-3.62 Mil
% of Total Estimate Gain
-36.21%

BML Capital Management, LLC's AN2 Therapeutics Inc Holding Summary

As of 2025-03-31, BML Capital Management, LLC held 5.75 Mil shares of AN2 Therapeutics Inc(ANTX), totaling $7.82 Mil. This investment constitutes 6.33% of their stock portfolio, and BML Capital Management, LLC now holds 19.1% of the outstanding AN2 Therapeutics Inc(ANTX) stock.

The initial trade took place in 2024Q3. And since then BML Capital Management, LLC has made 1 purchases of ANTX, at an average price of $1.74, for a total of 5.75 Mil shares. Based on historical transaction data and ANTX's current price of $1.11, BML Capital Management, LLC's estimated gain on his ANTX holdings is $-3.62 Mil, reflecting a -36.21% gain to date.

BML Capital Management, LLC ANTX ($1.11) Holding Chart

BML Capital Management, LLC ANTX ($1.11) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1